Paper · 19087311

Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice - lessons for tumor immunity.

Wagner AY and 4 others. BMC Cancer, 2008. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice - lessons for tumor immunity. Papers, record 19087311. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19087311

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice - lessons for tumor immunity.; PubMed
Journal: BMC Cancer; PubMed
Year: 2008; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/19087311/; PubMed
DOI: https://doi.org/10.1186/1471-2407-8-370; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC2628932/; PubMed
The journal: https://conductscience.org/library/journal-index/100967800; PubMed
Citations, by iCite: 1; iCite
Relative citation ratio, by iCite: 0.04; iCite
Revised in PubMed: 2021-10-20; PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Wagner AY	Alexander Y
2	Holle E	Eric
3	Holle L	Lori
4	Yu X	Xianzhong
5	Schwamberger G	Günter

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Graft Rejection	Major topic
Immune Tolerance	Major topic
Melanoma, Experimental	Major topic
Animals
Chimera
Leukocytes
Lymph Nodes
Mice
Mice, Inbred C57BL
Mice, Transgenic
Morula
Neoplasm Transplantation
T-Lymphocytes
T-Lymphocytes, Regulatory
Transplantation Tolerance

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	15,343,368	Self-representation in the thymus: an extended view.	Nat Rev Immunol	2004	https://conductscience.org/library/papers/15343368	PubMed
2	3,052,591	Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self.	Biochim Biophys Acta	1988	https://conductscience.org/library/papers/3052591	PubMed
3	13,775,333	Mouse chimaeras developed from fused eggs.	Nature	1961	https://conductscience.org/library/papers/13775333	PubMed
4	14,523,385	Roles of the NKG2D immunoreceptor and its ligands.	Nat Rev Immunol	2003	https://conductscience.org/library/papers/14523385	PubMed
5	3,951,539	Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.	Nature	1986	https://conductscience.org/library/papers/3951539	PubMed
6	1,987,491	Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice.	Nature	1991	https://conductscience.org/library/papers/1987491	PubMed
7	11,513,134	Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells.	Immunol Rev	2001	https://conductscience.org/library/papers/11513134	PubMed
8	9,853,820	Mouse chimaeras revisited: recollections and reflections.	Int J Dev Biol	1998	https://conductscience.org/library/papers/9853820	PubMed
9	6,235,727	The murine antitumor immune response and its therapeutic manipulation.	Adv Immunol	1984	https://conductscience.org/library/papers/6235727	PubMed
10	7,017,931	Studies in histocompatibility.	Science	1981	https://conductscience.org/library/papers/7017931	PubMed

1 to 10 of 58

See all 58 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMID	Title	Journal	Year	In Papers
20,854,686	Immunologgical self-tolerance in allophenic and embryo-aggregated mice.	Theor Biol Med Model	2010	https://conductscience.org/library/papers/20854686

Source PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19087311

GET https://conductscience.org/api/papers/v1/19087311/references?page=2

API reference For AI assistants